Home › Trial NCT00805012
Docetaxel and S-1 in Head and Neck Squamous Cell Carcinoma (HNSCC)
- Trial IDNCT00805012
- StatusTerminated
- PhasePhase 2
- Study typeInterventional
- SponsorSeoul National University Hospital
- Enrollment96
- Start date2008-12
- ConditionsHead and Neck Squamous Cell Carcinoma
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.